🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
1.330
-0.120 (-8.28%)
At close: Nov 19, 2026, 4:00 PM EST
1.320
-0.010 (-0.75%)
After-hours: Nov 19, 2026, 7:55 PM EST

CervoMed Statistics

Total Valuation

CervoMed has a market cap or net worth of $20.12 million. The enterprise value is $523,144.

Market Cap20.12M
Enterprise Value 523,144

Important Dates

The last earnings date was Friday, November 6, 2026, before market open.

Earnings Date Nov 6, 2026
Ex-Dividend Date n/a

Share Statistics

CervoMed has 15.13 million shares outstanding. The number of shares has increased by 23.36% in one year.

Current Share Class 15.13M
Shares Outstanding 15.13M
Shares Change (YoY) +23.36%
Shares Change (QoQ) +47.58%
Owned by Insiders (%) 25.92%
Owned by Institutions (%) 9.03%
Float 9.61M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 2,513.91
Forward PS n/a
PB Ratio 1.26
P/TBV Ratio 1.26
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 268.00
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.37, with zero debt.

Current Ratio 5.37
Quick Ratio 4.93
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -131.52% and return on invested capital (ROIC) is -84.24%.

Return on Equity (ROE) -131.52%
Return on Assets (ROA) -70.33%
Return on Invested Capital (ROIC) -84.24%
Return on Capital Employed (ROCE) -168.39%
Weighted Average Cost of Capital (WACC) -17.68%
Revenue Per Employee $582
Profits Per Employee -$1.90M
Employee Count15
Asset Turnover 0.00
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -83.98% in the last 52 weeks. The beta is -3.99, so CervoMed's price volatility has been lower than the market average.

Beta (5Y) -3.99
52-Week Price Change -83.98%
50-Day Moving Average 2.26
200-Day Moving Average 3.21
Relative Strength Index (RSI) 31.34
Average Volume (20 Days) 1,004,474

Short Selling Information

The latest short interest is 1.21 million, so 8.02% of the outstanding shares have been sold short.

Short Interest 1.21M
Short Previous Month 1.21M
Short % of Shares Out 8.02%
Short % of Float 12.61%
Short Ratio (days to cover) 3.54

Income Statement

In the last 12 months, CervoMed had revenue of $8,726 and -$28.52 million in losses. Loss per share was -$2.60.

Revenue8,726
Gross Profit -21.80M
Operating Income -29.23M
Pretax Income -28.52M
Net Income -28.52M
EBITDA n/a
EBIT -29.23M
Loss Per Share -$2.60
Full Income Statement

Balance Sheet

The company has $19.60 million in cash and no debt, with a net cash position of $19.60 million or $1.30 per share.

Cash & Cash Equivalents 19.60M
Total Debt n/a
Net Cash 19.60M
Net Cash Per Share $1.30
Equity (Book Value) 17.36M
Book Value Per Share 1.15
Working Capital 17.36M
Full Balance Sheet

Cash Flow

Operating Cash Flow -26.59M
Capital Expenditures n/a
Depreciation & Amortization n/a
Net Borrowing n/a
Free Cash Flow -26.59M
FCF Per Share -$1.76
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -334,924.87%
Pretax Margin -326,822.54%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CervoMed does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -23.36%
Shareholder Yield -23.36%
Earnings Yield -195.19%
FCF Yield -121.20%

Analyst Forecast

The average price target for CervoMed is $15.20, which is 1,042.86% higher than the current price. The consensus rating is "Strong Buy".

Price Target $15.20
Price Target Difference 1,042.86%
Analyst Consensus Strong Buy
Analyst Count 6
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

CervoMed has an Altman Z-Score of -3.84 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -3.84
Piotroski F-Score 1